Delivery Order SPE2DB20D9127-SPE2DB25FPRH0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (quantity: 120). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between the agency and the vendor. The award carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The contract, effective August 12, 2025 with completion by August 13, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, valued at $10,222.72, is scheduled for completion by July 31, 2025, and was issued on July 30, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $43,113.50 by the Defense Logistics Agency on August 20, 2025, for the supply of Xtandi 40 mg capsules (120-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and no set-aside designation was used in the award. Performance will occur at the contractor's facility in Park...
- The Defense Logistics Agency awarded a $4,311.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, carries no set-aside designation. Xtandi is a prescription oncology medication used in the treatment of prostate cancer, reflecting DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 2, 2025, for the supply of Xtandi 40 mg capsules (120-count) valued at $4,311.35. This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics support to the Department of Defense. The award carries no set-aside designation, and the contract specifies a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $25,868.10 by the Defense Logistics Agency for the supply of Xtandi 40 mg capsules (120-count units). The contract is firm fixed-price with an ultimate completion date of September 2, 2025, and carries no set-aside designation. This delivery order represents one of numerous pharmaceutical supply contracts issued to DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg tablets (120-count units). The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, utilizes a firm fixed-price contract type with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,792.31 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with completion expected by July 24, 2025. This delivery order was awarded without a set-aside designation, allowing the vendor to compete in the open...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRH0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, executed on September 2, 2025, with an ultimate completion date of September 3, 2025, carries no set-aside designation. The award leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, which maintains a ceiling value of $499,999,999 through November 2026 and authorizes the issuance of delivery orders for comprehensive pharmaceutical products supporting military healthcare facilities worldwide. Xtandi is an oncology medication used in the treatment of prostate cancer, reflecting the broader scope of DMS Pharmaceutical Group's federal contract portfolio, which encompasses prescription medications, biologics, vaccines, and specialized pharmaceutical products distributed to Department of Defense healthcare sites. The contractor's consistent performance as a preferred pharmaceutical supplier to the DLA demonstrates its established capability in delivering both brand-name and generic drugs to support military medical supply chains on a national scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 9/2/25 |